How Not to Run an Op-Ed Page
May 14th, 2013 |
7

On Mother’s Day, May 12, ethics Professor Carl Elliott had an Op-Ed published by the Minneapolis Star Tribune, “The University of Minnesota Research Case Needs Scrutiny.” The Star Tribune began to post comments, the first being: Minnesoda73 May. 12, 13 6:10 PM The University of Minnesota has investigated itself and found itself innocent. [...]
Keep reading »Yahrzeit – Reflections on Dan Markingson’s Legacy

This research ethics series uses the story of Dan Markingson’s participation in a clinical trial of anti-psychotic drugs at the University of Minnesota, his suicide 2004 while participating on the study, and subsequent events as a case study in which to explore various aspects of clinical trial conduct. In previous posts, I’ve looked at issues [...]
Keep reading »A Clinical Trial and Suicide Leave Many Questions: Part 6: The Run-Around, or Why I Now Call for an Independent Investigation of University of Minnesota
March 26th, 2013 |
41

This series uses the story of Dan Markingson’s participation in a clinical trial of anti-psychotic drugs at the University of Minnesota, his suicide 2004 while participating on the study, and subsequent events as a case study in which to explore various aspects of clinical trial conduct. In previous posts, I’ve looked at issues of [...]
Keep reading »Covering Clinical Trials: a message for journalists and critical readers

My message: Ask the hard questions. The Association of Health Care Journalists annual conference (#ahcj13) covered a variety of topics, with lectures and panels followed by question and answer sessions. As with many conferences, it was tough to choose between competing sessions. I learned a great deal about health care, databases, and resources to help [...]
Keep reading »A Clinical Trial and Suicide Leave Many Questions: Part 5: The Case of the Mysteriously Appearing Documents
March 12th, 2013 |
13

This series uses the story of Dan Markingson’s participation in a clinical trial of anti-psychotics at the University of Minnesota, his ultimate suicide while participating on the study, and subsequent events as a case study in which to explore various aspects of clinical trial conduct. In previous posts, we’ve looked at issues of “good clinical [...]
Keep reading »A Clinical Trial and Suicide Leave Many Questions: Part 4: The University of Minnesota’s Response
January 8th, 2013 |
6

In earlier posts, we’ve looked at issues of consent, investigator responsibilities, and conflicts of interest on the case of Dan Markingson’s suicide while participating in a clinical trial of anti-psychotics at the University of Minnesota. This time, we turn to the University’s response. Not surprisingly, the University has claimed it has no responsibility for any [...]
Keep reading »A Clinical Trial and Suicide Leave Many Questions: Part 1: Consent?
December 11th, 2012 |
5

The suicide of Dan Markingson, a 26 year old man participating in a psychiatric trial, has again made the news, and will serve us for a life-time of study and discussion of research ethics, along with the TeGenero and Jesse Gelsinger cases. Markingson began to show signs of paranoia and delusions in 2003, [...]
Keep reading »From the Holocaust to Thalidomide: A Nazi Legacy
November 8th, 2012 |
4

I was attending World Federation of Jewish Child Survivors of the Holocaust and Descendants 24th Annual International Conference in Cleveland last week, when my aunt, herself a survivor, handed me a copy of Newsweek with a cover article, “The Nazis and Thalidomide: The Worst Drug Scandal of All Time.” The story was prompted by the [...]
Keep reading »Anthrax vaccine – To the victor, the spoils

In my last post, we began to play “Follow the Money” to better understand the history of the anthrax vaccine and the current proposal to test the vaccine on children. Conflicts of Interest-Case Study Major issues with the anthrax vaccine include safety, conflicts of interest and the lobbying power of the drug developer. I don’t [...]
Keep reading »Anthrax, anthrax, everywhere…
May 22nd, 2012 |
5

This past week brought news about another successful bioterrorism response drill, effectively delivering hypothetical medicines to protect the citizens of Baltimore from a hypothetical anthrax attack. Frankly, I always shake my head in dismay when I read of such preparedness exercises. I think back to my childhood, with its “duck and cover” Cuban missile crisis [...]
Keep reading »







See what we're tweeting about



